Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV

Status:
Completed

Trial end date:
2007-05-01

Target enrollment:

Participant gender:

Safety and Efficacy of Paraplatin in combination with Taxol in patients of 70 years or older with epithelial ovary cancer F.I.G.O. stages III and IV.

Phase 2

ARCAGY/ GINECO GROUP

Carboplatin
Paclitaxel